Skip to main content
Equibles

TWO SIGMA INVESTMENTS, LP

Position in ALLO — Allogene Therapeutics, Inc.

CIK 1179392 NEW YORK, NY
Back to ALLO Full portfolio

Position in ALLO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$16,191,443
+$3,075,331 QoQ
Shares Held
7,784,348
+44.8% QoQ
Ownership
2.25%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#11
of 209 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in ALLO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $7,283,390,440 across 343 Biotechnology names. ALLO ranks #66 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
 1,875,937 $564,713,315
2 MRNA
Moderna, Inc.
 7,193,530 $503,762,905
3 IONS
Ionis Pharmaceuticals Inc
 6,252,342 $495,748,197
4 REGN
Regeneron Pharmaceuticals, Inc.
 656,124 $409,119,558
5 BBIO
BridgeBio Pharma, Inc.
 4,722,185 $351,708,338
6 EXEL
Exelixis, Inc.
 4,209,861 $229,058,537
7 INCY
Incyte Corp
 2,003,559 $227,123,448
8 ARGX
Argenx SE
 185,638 $172,229,367

All Filings in ALLO

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $16,191,443 7,784,348
2026-03-31 $13,116,112 5,375,456
2025-12-31 $4,690,114 3,423,441
2025-09-30 $4,195,718 3,383,644
2025-06-30 $1,822,944 1,613,225
2025-03-31 $3,029,644 2,075,099
2024-12-31 $5,776,856 2,712,139
2024-09-30 $7,834,316 2,797,970
2024-06-30 $6,898,368 2,960,673
2024-03-31 $8,543,680 1,911,338
2023-12-31 $7,429,676 2,314,541
2023-09-30 $4,121,700 1,300,221
2023-06-30 $9,705,316 1,952,780
2023-03-31 $9,271,140 1,876,749
2022-12-31 $10,134,775 1,611,252
2022-09-30 $8,996,011 832,964
2022-06-30 $1,813,489 159,078
2022-03-31 $8,692,434 954,164
2021-12-31 $2,831,681 189,791
2021-06-30 $817,842 31,359
2021-03-31 $6,796,591 192,538
2020-12-31 $8,673,069 343,624
2020-09-30 $13,750,876 364,648
2020-06-30 $10,850,288 253,393